MCHPP vs NVDA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 18, 2026
MCHPP
NVDA
Investment Advisor Scores
NVDA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MCHPP | NVDA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 24.2131 | Tie |
| PEG Ratio | 0 | 0.654 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 35.1% | 85.2% | NVDA |
| Earnings Growth | -81.6% | 214.5% | NVDA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.8/100 | 59.3/100 | NVDA |
| Profit Margin | 4.9% | 63.0% | NVDA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MCHPP
MarkdownPrice below a falling SMA50 (slope -5.4%), weak momentum, RSI 38
NVDA
NeutralMixed signals - no dominant trend phase, RSI 53
Fundamentals Snapshot
| Metric | MCHPP | NVDA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 26.3 |
| Trailing P/E | — | 30.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.9% |
| Gross Margin | 0.6% | 0.7% |
| Operating Margin | 0.2% | 0.7% |
| EPS | 0.00 | 6.52 |
| Dividend Yield | 0.03% | 0.00% |